Trial intelligence / Profile preview

TREAT: Estradiol Regimens in Transgender Women

NCT05010707Phase 2Completed

Sponsor
Washington University School of Medicine
Start
Aug 2021
Primary completion
Aug 2023
Countries
1
01

Overview

A Phase 2 trial of estradiol topical in gender dysphoria (GD), sponsored by Washington University School of Medicine. Started Aug 2021; status: completed.

02

Drugs

estradiol topical
03

Conditions

gender dysphoria (GD)

Beyond the preview

Go deeper on NCT05010707.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05010707.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call